Pharmaceuticals Australia

Australia Pharmaceuticals Market Analysis, 2024–2034

Updated Reviewed by Vidhi Upadhyay

Australia Pharmaceuticals Market Industry Trends and Forecast to 2034: Segmented by (Product, Route, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Australia · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $17.87 Bn Placeholder estimate
Estimate 2025 $19.18 Bn 1.2% of the global market
Projected 2034 $36.16 Bn 88.5% Adds $16.98 Bn over 9 forecast years
CAGR 2025–2034 7.3% Faster than 21% of 183 Pharmaceuticals markets here
Key players 6 +1
  • Australia is 1.15% of the global market.
  • In APAC, the largest is China at $155.76 Bn.
  • Fastest growing: India at 9.2% a year.
  • Australia ranks 5th of 14 by size in APAC.

Market size projection

Australia

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$16.98 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Pharmaceuticals Market market size by year, Australia
YearMarket sizeChange that yearSince 2025
2024 (estimate) $17.87 Bn — —
2025 (base) $19.18 Bn +$1.30 Bn —
2026 (forecast) $20.58 Bn +$1.40 Bn +7.3%
2027 (forecast) $22.08 Bn +$1.50 Bn +15.1%
2028 (forecast) $23.69 Bn +$1.61 Bn +23.5%
2029 (forecast) $25.42 Bn +$1.73 Bn +32.6%
2030 (forecast) $27.28 Bn +$1.86 Bn +42.2%
2031 (forecast) $29.27 Bn +$1.99 Bn +52.6%
2032 (forecast) $31.40 Bn +$2.14 Bn +63.8%
2033 (forecast) $33.70 Bn +$2.29 Bn +75.7%
2034 (forecast) $36.16 Bn +$2.46 Bn +88.5%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Report snapshot

Australia Pharmaceuticals Market Analysis at a glance
Market size, 2025$19.18 Bn placeholder estimate
Forecast, 2034$36.16 Bn placeholder estimate
Growth (CAGR), 2025–20347.3% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsProduct, route and end user (see all)
Key playersPfizer Inc., Johnson & Johnson, Roche, Novartis AG, Merck & Co., Inc. and 1 more (see all)
Regulator in AustraliaTGASource: Therapeutic Goods Administration. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Australia Pharmaceuticals Market Analysis Executive Summary

Pharmaceuticals are the medicines, branded and generic, that prevent, treat and cure disease in people.

Key segments of the pharmaceuticals market include product (Branded Drugs, Generic Drugs and Biologics) and route (Oral, Injectable and Topical).

Bar chart: Australia Pharmaceuticals market size, 2024–2034, placeholder estimates. $17.87 Bn in 2024, $19.18 Bn in 2025 and $36.16 Bn in 2034, 7.3% CAGR.
Australia Pharmaceuticals market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Australia Pharmaceuticals Market Dynamics

Market Growth Drivers

Ageing populations, more chronic disease, broader access to medicines and steady new drug approvals are driving the pharmaceuticals market.

Opportunity

Personalized treatments, local manufacturing and new technologies for making medicines give the pharmaceuticals market room to grow.

Market Restraints

Price controls, long and costly development, patent expiries and strict quality rules hold back the pharmaceuticals market.

Competitive Landscape for Pharmaceuticals Market in Australia

The pharmaceuticals market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Pharmaceuticals Market in Australia

Pharmaceuticals in Australia: rules and payment

Medicines must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied.⁠[1] Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines.⁠[2]

[1] Therapeutic Goods Administration. Checked 14 Nov 2026.

[2] Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for pharmaceuticals. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Australia.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Pharmaceuticals right now, from free public sources.

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Pharmaceuticals in context

Australia compared

  • Health spending per person: 6,980 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 17 countries we cover in APAC.[1]
  • Doctors: 4.09 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). Highest of the 17 countries we cover in APAC.[2]
  • People aged 65 and over: 18.1% of people (2025). World: 10.4% of people (2025). 4th highest of the 18 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 20 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 20 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 21 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Pharmaceuticals market in Australia?
Placeholder estimate: about $19.18 Bn in 2025, rising to about $36.16 Bn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Pharmaceuticals market in Australia growing?
Placeholder estimate: about 7.3% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Pharmaceuticals market report cover?
The report splits the market by product (Branded Drugs, Generic Drugs, Biologics, Vaccines), route (Oral, Injectable, Topical, Inhaled) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the Pharmaceuticals market?
Key players include Pfizer Inc., Johnson & Johnson, Roche, Novartis AG, Merck & Co., Inc. and AbbVie Inc..
What is driving the Pharmaceuticals market?
Ageing populations, more chronic disease, broader access to medicines and steady new drug approvals are driving the pharmaceuticals market.
Who regulates Pharmaceuticals in Australia?
Medicines must be included in the Australian Register of Therapeutic Goods (ARTG), run by the Therapeutic Goods Administration (TGA), before they can be supplied. Source: Therapeutic Goods Administration. Checked 14 Nov 2026.
How is healthcare paid for in Australia?
Medicare pays for public hospital care and many doctor visits, and the Pharmaceutical Benefits Scheme (PBS) subsidises listed medicines. Source: Pharmaceutical Benefits Scheme. Checked 14 Nov 2026.
Back to Catalogue

Related Pharmaceuticals reports in Australia

See all

Related on drug development and manufacturing and biologics and biosimilars

See the topic